HTLV-1-Related Malignant Neoplasm — Trials

HTLV-1-Related Malignant Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

121 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 10
Recruiting: 8
Ph III recruiting: 0
Growth YoY: —
Industry share: 20%
Top sponsor: Carlos Brites
Termination share: 28.6%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (27)

clinicaltrialsPublishedShowing 51–56 of 56 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT00005950	506U78 in Treating Patients With Recurrent or Refractory Non-Hodgkin's Lymphoma or T-cell Lymphoma	terminated	Phase 2	111	National Cancer Institute (NCI)NIH	1	Jan 23, 2013	clinicaltrials
NCT00006473	Oxaliplatin in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma	completed	Phase 2	72	National Cancer Institute (NCI)NIH	1	Jan 23, 2013	clinicaltrials